NCT06535334View on ClinicalTrials.gov

Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

May 31, 2026

Conditions
Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Interventions
DRUG

Chemotherapy

Intravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer

Trial Locations (1)

22050

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER

NCT06535334 - Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter